Previous studies debated the role of NGF in pulmonary pathologies, alluding to the possibility of considering the NGF signaling as a potential diagnostic/therapeutic target in SARS-CoV-2-induced pulmonary complications [34], contributing to the antibody production in convalescent COVID-19 [35]. Here, NGF is linked to COVID-19.